[HTML][HTML] SIRT1 signaling pathways in sarcopenia: Novel mechanisms and potential therapeutic targets

L Yang, D Liu, S Jiang, H Li, L Chen, Y Wu… - Biomedicine & …, 2024 - Elsevier
Sarcopenia is an aging-related skeletal disease characterized by decreased muscle mass,
strength, and physical function, severely affecting the quality of life (QoL) of the elderly …

Myoprotective whole foods, muscle health and sarcopenia in older adults

A Granic, R Cooper, SM Robinson… - Current Opinion in …, 2024 - journals.lww.com
Myoprotective whole foods, muscle health and sarcopenia in o... : Current Opinion in Clinical
Nutrition & Metabolic Care Myoprotective whole foods, muscle health and sarcopenia in older …

Get fit: muscle health for Crohn's Disease Surgical Outcome optimization

S Massironi, P Sileri, S Danese - Inflammatory Bowel Diseases, 2023 - academic.oup.com
Get Fit: Muscle Health for Crohn’s Disease Surgical Outcome Optimization Page 1 Inflammatory
Bowel Diseases, 2023, XX, 1–4 https://doi.org/10.1093/ibd/izad235 Advance access publication …

[HTML][HTML] Higher ultra processed foods intake is associated with low muscle mass in young to middle-aged adults: a cross-sectional NHANES study

W Kong, Y Xie, J Hu, W Ding, C Cao - Frontiers in Nutrition, 2024 - frontiersin.org
Design Ultra-processed foods (UPFs) have become a pressing global health concern,
prompting investigations into their potential association with low muscle mass in adults …

[HTML][HTML] A mito-centric view on muscle aging and function

J Burtscher, B Strasser, M Burtscher - Frontiers in Public Health, 2024 - frontiersin.org
Healthy lifestyles, such as those that include regular physical activity and a balanced diet,
are a powerful means to prevent chronic disease and age-related functional decline. A …

The Current Landscape of Pharmacotherapies for Sarcopenia

G Bahat, S Ozkok - Drugs & Aging, 2024 - Springer
Sarcopenia is a skeletal muscle disorder characterized by progressive and generalized
decline in muscle mass and function. Although it is mostly known as an age-related disorder …

Are we underestimating the potential of neuroactive drugs to augment neuromotor function in sarcopenia?

LBR Orssatto, JR Thorstensen… - Metabolism-Clinical …, 2024 - metabolismjournal.com
Sarcopenia is a skeletal muscle disease characterised by exacerbated loss of muscle mass,
strength, and/or impaired function with aging and/or disease [2–7]. Historically, the term …

[HTML][HTML] Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both

R Wong, LY Yuan - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
Sarcopenia and metabolic dysfunction associated steatotic liver disease (MASLD) are
closely intertwined. Sarcopenia, traditionally a disease of the older adult and chronic …

Dynapenic abdominal obesity and incident functional disability: Results from a nationwide longitudinal study of middle-aged and older adults in China

S Qian, Q Wen, T Huang, J Chen, X Feng - Archives of Gerontology and …, 2024 - Elsevier
Background There is little epidemiological evidence on the relationship of dynapenic
abdominal obesity (DAO) and the development of functional disability, particularly in Asian …

[HTML][HTML] Nutritional Screening, Initial Management and Referral for Older People with Sarcopenia or Frailty-Results from a UK-Wide Survey

C Bowler, E Moriarty, M Chawner, A Clegg… - Journal of Frailty …, 2024 - ncbi.nlm.nih.gov
Objectives: We surveyed healthcare staff working with older people to understand current
practice in nutrition screening, initial management and referral for older people with …